Literature DB >> 16037639

Quantitative analysis of chemotherapeutic effects in tumors using in vivo staining and correlative histology.

Heung Kook Choi1, Doreen Yessayan, Hyun Ju Choi, Eyk Schellenberger, Alex Bogdanov, Lee Josephson, Ralph Weissleder, Vasilis Ntziachristos.   

Abstract

AIMS: To microscopically analyze the chemotherapeutic response of tumors using in vivo staining based on an annexinV-Cy5.5 probe and independently asses their apoptotic count using quantitative histological analysis.
METHODS: Lewis Lung Carcinomas cells, that are sensitive (CS-LLC) and resistant (CR-LLC) to chemotherapy were implanted in nude mice and grown to tumours. Mice were treated with cyclophosphamide and injected with a Cy5.5-annexinV fluorescent probe. In vivo imaging was performed using Fluorescence Molecular Tomography. Subsequently tumours were excised and prepared for histology. The histological tumour sections were stained for apoptosis using a terminal deoxynucleotidyl transferase-mediated nick end labeling (TUNEL) assay. A minimum of ten tissue sections were analyzed per tumour for apoptosis quantification by TUNEL staining and corresponding Cy5.5 distribution.
RESULTS: We detected higher levels of apoptosis and corresponding higher levels of Cy5.5 fluorescence in the CS-LLC vs. the CR-LLC tumours. The cell count rate on CS-LLC sections over CR-LLC was found to be approximately 2 :1 where the corresponding area observed on Cy5.5 distribution measurements revealed a approximately 1.7 :1 ratio of CS-LLC over CR-LLC. These observations are consistent with the higher apoptotic index expected from the CS-LLC cell line.
CONCLUSIONS: Quantitative analysis of histological slices revealed higher fluorescence and higher apoptotic count in the CS-LLC tumour images compared to the CR-LLC tumour images. These observations demonstrate that the annexinV-Cy5.5 probe sensed the chemotherapeutic effect of cyclophospamide and further confirmed in vivo FMT measurements.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16037639      PMCID: PMC4615174          DOI: 10.1155/2005/791936

Source DB:  PubMed          Journal:  Cell Oncol        ISSN: 1570-5870            Impact factor:   6.730


  5 in total

1.  Imaging of glioma tumor with endogenous fluorescence tomography.

Authors:  Dax S Kepshire; Summer L Gibbs-Strauss; Summer L Gibbs-Struass; Julia A O'Hara; Michael Hutchins; Niculae Mincu; Frederic Leblond; Mario Khayat; Hamid Dehghani; Subhadra Srinivasan; Brian W Pogue
Journal:  J Biomed Opt       Date:  2009 May-Jun       Impact factor: 3.170

2.  A low molecular weight zinc2+-dipicolylamine-based probe detects apoptosis during tumour treatment better than an annexin V-based probe.

Authors:  Karin Palmowski; Anne Rix; Wiltrud Lederle; Florian F Behrendt; Felix M Mottaghy; Brian D Gray; Koon Y Pak; Moritz Palmowski; Fabian Kiessling
Journal:  Eur Radiol       Date:  2014-02       Impact factor: 5.315

3.  In vivo investigation of breast cancer progression by use of an internal control.

Authors:  John Baeten; Jodi Haller; Helen Shih; Vasilis Ntziachristos
Journal:  Neoplasia       Date:  2009-03       Impact factor: 5.715

4.  Failure of annexin-based apoptosis imaging in the assessment of antiangiogenic therapy effects.

Authors:  Wiltrud Lederle; Susanne Arns; Anne Rix; Felix Gremse; Dennis Doleschel; Jörn Schmaljohann; Felix M Mottaghy; Fabian Kiessling; Moritz Palmowski
Journal:  EJNMMI Res       Date:  2011-11-17       Impact factor: 3.138

5.  Near infrared planar tumor imaging and quantification using nanosized Alexa 750-labeled phospholipid micelles.

Authors:  Aristarchos Papagiannaros; Amit Kale; Tatyana S Levchenko; Dmitry Mongayt; William C Hartner; Vladimir P Torchilin
Journal:  Int J Nanomedicine       Date:  2009-04-20
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.